Zeto Secures $31M to Advance EEG Brain Monitoring Technology

Zeto, a leading innovator in non-invasive brain monitoring technology, has successfully raised $31 million in a funding round to further develop and scale its electroencephalography (EEG) brain monitoring solutions. The investment will allow the company to enhance its product offerings, accelerate clinical research, and expand its reach into both healthcare and research sectors.

The funding round was led by prominent venture capital firms, with participation from existing investors who recognize Zeto’s potential to revolutionize brain health monitoring. The newly raised capital will be directed toward advancing Zeto’s cutting-edge EEG technology, which promises to improve patient care, streamline clinical workflows, and provide real-time, actionable insights into brain activity.

Founded in 2018, Zeto has developed a breakthrough in EEG technology by creating a portable, easy-to-use system that provides clinicians with highly accurate brain activity data. Traditional EEG systems often involve cumbersome equipment and long setup times, limiting their use in many clinical settings. Zeto’s solution, in contrast, offers a lightweight, wireless headset that can be applied quickly and seamlessly, making it ideal for use in hospitals, clinics, and even in-home care environments. This user-friendly approach opens new possibilities for EEG monitoring, enabling more frequent and widespread use of brain activity assessments.

“We are thrilled to have secured this new round of funding, which will allow us to accelerate our efforts in transforming brain health monitoring,” said Dr. Sarah Thompson, CEO and co-founder of Zeto. “EEG technology has long been an essential tool in diagnosing and managing neurological conditions, but traditional systems have been limited by their complexity and lack of portability. Our platform enables clinicians to monitor brain activity in real time, improving diagnostic accuracy and helping to deliver better patient outcomes.”

EEG technology has been used for decades to diagnose and monitor a range of neurological conditions, including epilepsy, sleep disorders, and brain injuries. However, traditional EEG systems are often bulky, expensive, and require highly trained professionals to operate, which can result in delays in diagnosis and treatment. Zeto’s wireless EEG headset is designed to address these challenges by providing a portable, cost-effective solution that can be used in various clinical settings and even in the comfort of a patient’s home.

The company’s flagship product is a wearable EEG system that records brain activity using a lightweight, flexible headset equipped with advanced sensors. The headset transmits real-time data to a cloud-based platform where it is analyzed using artificial intelligence (AI) and machine learning (ML) algorithms to detect abnormalities and generate insights. The system can be used for continuous monitoring, making it particularly useful for patients with conditions such as epilepsy, traumatic brain injury, and sleep disorders, as well as for researchers conducting clinical studies.

Zeto’s platform is already receiving positive feedback from healthcare providers and researchers, who appreciate the ease of use and accuracy of the system. The company has formed partnerships with leading hospitals and research institutions to conduct clinical trials and further validate the technology’s potential to improve patient care. The new funding will enable Zeto to expand its clinical research efforts and refine its platform based on real-world data.

“We are excited to support Zeto as they work to make EEG brain monitoring more accessible, efficient, and effective,” said James Miller, General Partner at VentureHealth Partners, one of the lead investors in the funding round. “Zeto’s approach has the potential to significantly enhance the way neurological conditions are diagnosed and managed, and we believe their technology will play a key role in the future of brain health.”

In addition to its clinical applications, Zeto’s technology is also poised to play a significant role in neuroscience research. By enabling more frequent and accurate monitoring of brain activity, the system can provide valuable insights into the brain’s functioning, helping researchers uncover new findings and develop better treatments for neurological diseases. Zeto’s AI-powered platform also has the potential to assist in early detection and prediction of neurological conditions, offering hope for patients who may benefit from earlier intervention.

With the $31 million in funding, Zeto is well-positioned to expand its reach and continue improving its technology. The company plans to enhance the functionality of its platform, expand its customer base, and explore new applications in both healthcare and research. Zeto’s commitment to innovation in brain health monitoring is setting the stage for a new era of neurological care, where patients benefit from more timely, accurate, and personalized assessments of their brain health.

As the global demand for advanced healthcare technologies continues to grow, Zeto’s wireless EEG solution is poised to become a critical tool in improving brain health management and transforming the way neurological conditions are diagnosed and treated. With its strong backing and a clear vision for the future, Zeto is on track to make a lasting impact on both the healthcare industry and the lives of patients around the world.